Загрузка...
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers
We evaluated antibody responses to the human immunodeficiency virus (HIV) envelope variable regions 1 and 2 (V1V2) in 29 vaccinees who had received three HIV-1 DNA immunizations and two HIV-modified vaccinia virus Ankara (MVA) boosts in the phase I/II HIVIS03 vaccine trial. Twenty vaccinees received...
Сохранить в:
| Опубликовано в: : | Vaccines (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7711440/ https://ncbi.nlm.nih.gov/pubmed/33202967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040681 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|